El Shaikh MA - Search Results

1

Radiosensitization by gemcitabine fixed-dose-rate infusion versus bolus injection in a pancreatic cancer model.

Morgan M, El Shaikh MA, Abu-Isa E, Davis MA, Lawrence TS. Morgan M, et al. Among authors: el shaikh ma. Transl Oncol. 2008 Mar;1(1):44-9. doi: 10.1593/tlo.07118. Transl Oncol. 2008. PMID: 18607504 Free PMC article.

2

Radiotherapy: what can be achieved by technical improvements in dose delivery?

Moran JM, Elshaikh MA, Lawrence TS. Moran JM, et al. Lancet Oncol. 2005 Jan;6(1):51-8. doi: 10.1016/S1470-2045(04)01713-9. Lancet Oncol. 2005. PMID: 15629276 Review.

3

The prognostic significance of age in surgically staged patients with Type II endometrial carcinoma.

Vance S, Yechieli R, Cogan C, Hanna R, Munkarah A, Elshaikh MA. Vance S, et al. Gynecol Oncol. 2012 Jul;126(1):16-9. doi: 10.1016/j.ygyno.2012.04.011. Epub 2012 Apr 13. Gynecol Oncol. 2012. PMID: 22507535

4

Enhancement of tumor radioresponse in vivo by gemcitabine.

Milas L, Fujii T, Hunter N, Elshaikh M, Mason K, Plunkett W, Ang KK, Hittelman W. Milas L, et al. Cancer Res. 1999 Jan 1;59(1):107-14. Cancer Res. 1999. PMID: 9892194

5

Maximizing therapeutic gain with gemcitabine and fractionated radiation.

Mason KA, Milas L, Hunter NR, Elshaikh M, Buchmiller L, Kishi K, Hittelman K, Ang KK. Mason KA, et al. Int J Radiat Oncol Biol Phys. 1999 Jul 15;44(5):1125-35. doi: 10.1016/s0360-3016(99)00134-0. Int J Radiat Oncol Biol Phys. 1999. PMID: 10421547

6

Prophylactic tamsulosin (Flomax) in patients undergoing prostate 125I brachytherapy for prostate carcinoma: final report of a double-blind placebo-controlled randomized study.

Elshaikh MA, Ulchaker JC, Reddy CA, Angermeier KW, Klein EA, Chehade N, Altman A, Ciezki JP. Elshaikh MA, et al. Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):164-9. doi: 10.1016/j.ijrobp.2004.09.036. Int J Radiat Oncol Biol Phys. 2005. PMID: 15850917 Clinical Trial.

7

Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report.

Jabbari S, Kim HM, Feng M, Lin A, Tsien C, Elshaikh M, Terrel JE, Murdoch-Kinch C, Eisbruch A. Jabbari S, et al. Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):725-31. doi: 10.1016/j.ijrobp.2005.02.045. Int J Radiat Oncol Biol Phys. 2005. PMID: 16199308

8

Hysterectomy for uterine adenocarcinoma in the elderly: tumor characteristics, and long-term outcome.

Gayar OH, Robbins JR, Parikh K, Lu M, Buekers T, Munkarah A, Elshaikh MA. Gayar OH, et al. Gynecol Oncol. 2011 Oct;123(1):71-5. doi: 10.1016/j.ygyno.2011.06.036. Epub 2011 Jul 20. Gynecol Oncol. 2011. PMID: 21767871

9

Is time to recurrence after hysterectomy predictive of survival in patients with early stage endometrial carcinoma?

Robbins JR, Yechieli R, Laser B, Mahan M, Rasool N, Elshaikh MA. Robbins JR, et al. Gynecol Oncol. 2012 Oct;127(1):38-42. doi: 10.1016/j.ygyno.2012.06.042. Epub 2012 Jul 11. Gynecol Oncol. 2012. PMID: 22796549

10

The impact of income on clinical outcomes in FIGO stages I to II endometrioid adenocarcinoma of the uterus.

Robbins JR, Mahan MG, Krajenta RJ, Munkarah AR, Elshaikh MA. Robbins JR, et al. Am J Clin Oncol. 2013 Dec;36(6):625-9. doi: 10.1097/COC.0b013e31825eb386. Am J Clin Oncol. 2013. PMID: 22892431

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

140 results

Search Page

Filters